Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 9/3043% below fair value
$2.33−0.90 (-27.80%)
Close on Nov 13, 2026Market cap $38.27MP/E –Yield –
Sensus Healthcare profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Sensus Healthcare's profit margin for the twelve months ending Jun 30, 2026 was -88.5%. For fiscal 2025 it was -28.1%, against 15.9% the year before. The highest annual figure on record is 54.4% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -28.1% | −44.0 |
| FY2024 | Dec 31, 2024 | 15.9% | +13.9 |
| FY2023 | Dec 31, 2023 | 2.0% | −52.5 |
| FY2022 | Dec 31, 2022 | 54.4% | +39.2 |
| FY2021 | Dec 31, 2021 | 15.2% | +86.6 |
| FY2020 | Dec 31, 2020 | -71.4% | −65.1 |
| FY2019 | Dec 31, 2019 | -6.2% | +1.4 |
| FY2018 | Dec 31, 2018 | -7.7% | +10.4 |
| FY2017 | Dec 31, 2017 | -18.0% | −15.7 |
| FY2016 | Dec 31, 2016 | -2.3% | −0.0 |
| FY2015 | Dec 31, 2015 | -2.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -382.1% | −367.9 |
| Q1 FY2026 | Mar 31, 2026 | -77.4% | −46.5 |
| Q4 FY2025 | Dec 31, 2025 | -64.1% | −76.0 |
| Q3 FY2025 | Sep 30, 2025 | -13.7% | −27.4 |
| Q2 FY2025 | Jun 30, 2025 | -14.2% | −31.6 |
| Q1 FY2025 | Mar 31, 2025 | -30.8% | −52.2 |
| Q4 FY2024 | Dec 31, 2024 | 11.8% | −21.7 |
| Q3 FY2024 | Sep 30, 2024 | 13.7% | +51.0 |
| Q2 FY2024 | Jun 30, 2024 | 17.4% | +25.8 |
| Q1 FY2024 | Mar 31, 2024 | 21.3% | +76.8 |
| Q4 FY2023 | Dec 31, 2023 | 33.5% | +11.9 |
| Q3 FY2023 | Sep 30, 2023 | -37.2% | −57.5 |
| Q2 FY2023 | Jun 30, 2023 | -8.4% | −37.6 |
| Q1 FY2023 | Mar 31, 2023 | -55.5% | −210.8 |
| Q4 FY2022 | Dec 31, 2022 | 21.6% | −19.2 |
| Q3 FY2022 | Sep 30, 2022 | 20.3% | +16.8 |
| Q2 FY2022 | Jun 30, 2022 | 29.2% | +34.3 |
| Q1 FY2022 | Mar 31, 2022 | 155.4% | +191.7 |
| Q4 FY2021 | Dec 31, 2021 | 40.8% | +20.8 |
| Q3 FY2021 | Sep 30, 2021 | 3.5% | +108.0 |
| Q2 FY2021 | Jun 30, 2021 | -5.1% | +212.4 |
| Q1 FY2021 | Mar 31, 2021 | -36.3% | +177.3 |
| Q4 FY2020 | Dec 31, 2020 | 20.0% | +7.8 |
| Q3 FY2020 | Sep 30, 2020 | -104.4% | −91.9 |
| Q2 FY2020 | Jun 30, 2020 | -217.6% | −219.1 |
| Q1 FY2020 | Mar 31, 2020 | -213.6% | −174.6 |
| Q4 FY2019 | Dec 31, 2019 | 12.2% | +11.0 |
| Q3 FY2019 | Sep 30, 2019 | -12.5% | −5.3 |
| Q2 FY2019 | Jun 30, 2019 | 1.5% | +10.4 |
| Q1 FY2019 | Mar 31, 2019 | -39.0% | −20.1 |
| Q4 FY2018 | Dec 31, 2018 | 1.3% | +7.6 |
| Q3 FY2018 | Sep 30, 2018 | -7.2% | +12.9 |
| Q2 FY2018 | Jun 30, 2018 | -8.9% | +6.5 |
| Q1 FY2018 | Mar 31, 2018 | -18.9% | +17.2 |
| Q4 FY2017 | Dec 31, 2017 | -6.3% | −7.0 |
| Q3 FY2017 | Sep 30, 2017 | -20.1% | −19.2 |
| Q2 FY2017 | Jun 30, 2017 | -15.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -36.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 0.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -0.9% | – |
See a number that looks wrong?